-- Michael J. Farrell, Director, Chairman and CEO, on April 07, 2026, sold 4,991 shares in Resmed (RMD) for $1,125,486. Following the Form 4 filing with the SEC, Farrell has control over a total of 468,313 common shares of the company, with 466,223 shares held directly and 2,090 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/943819/000094381926000021/xslF345X05/form4.xml
Price: $228.88, Change: $-1.82, Percent Change: -0.79%